HARMONY IN DIVERSITY is the first study of combined neurotoxin and filler treatment in adults on glucagon-like peptide-1 (GLP-1) medications. In this Phase 4 cohort, participants reported statisticall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results